Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with potential antidepressant, anxiolytic, or antipsychotic properties. The presence of the trifluoromethoxy group enhances metabolic stability and lipophilicity, improving blood-brain barrier penetration. It is also employed in the preparation of novel bioactive molecules for research in neuropharmacology and medicinal chemistry.